ATC Group: A10BF Alpha glucosidase inhibitors

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A10BF in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs used in diabetes
3
Blood glucose lowering drugs, excl. insulins
4
A10BF
Alpha glucosidase inhibitors

Group A10BF contents

Code
Title
Acarbose
Miglitol
Voglibose

Active ingredients in A10BF

Active Ingredient
Description

Acarbose is an alpha-glucosidase inhibitors, used in the treatment of diabetes. Inhibitors of a-glucosidase retard the breakdown of carbohydrates in the food and reduce the increase in blood glucose levels, which occurs after each meal.

Miglitol is a reversible inhibitor of intestinal alpha-glucosidases. Under the influence of miglitol, the digestion of complex carbohydrates into absorbable monosaccharides in the small intestine is dosedependently delayed. Administration of miglitol thus leads to reduced postprandial hyperglycaemia and a smoothing effect on fluctuations in the daily blood glucose profile.

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK